Commitment to Patient Access Genentech is committed to patients having access to our therapies. Through its Genentech Access Solutions program, the company provides patients and healthcare providers with coverage and reimbursement support, patient assistance and informational resources. Patient assistance support is for those eligible patients in the United States who do not have insurance coverage or who cannot afford their out-of-pocket co-pay costs.

• Since 1985, when our first product was approved, Genentech has donated approximately $2.3 billion in free medicine to uninsured patients through its Genentech® Access to Care Foundation (GATCF) and other charitable programs.
• The company recently expanded GATCF to provide free drug to eligible patients who have private insurance and have met or exceeded their lifetime maximum benefits.
• In February 2007, the company announced the expansion of GATCF to help address the needs of financially eligible patients enrolled in a Medicare Part D plan who are prescribed Tarceva® (erlotinib).

Genentech Access Solutions For patients and their health care providers, Genentech Access Solutions provides coverage and reimbursement support, patient assistance and information resources. For more information on potential assistance options, please call (866) 4 ACCESS or visit GenentechAccessSolutions.com.

Co-pay Assistance Since 2005, Genentech has donated approximately $550 million to independent non-profit organizations that provide co-pay assistance. To learn more about these independent, public charities, patients can speak with a specialist from Genentech's Access Solutions group by calling (866) 4 ACCESS or visiting GenentechAccessSolutions.com.

Avastin Patient Assistance Program The Avastin Patient Assistance program provides an opportunity for physicians and eligible patients who are treated for an FDA-approved indication and who reach an annual dosage of 10,000 mg to receive free Avastin from Genentech for the remainder of the 12-month period.

This program is open to all patients receiving Avastin regardless of insurance coverage and is accessible through the Genentech Access Solutions program.

For more information, please call (866) 4 ACCESS or visit GenentechAccessSolutions.com